Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Theme
Reconnoitering the Challenges in the Era of Dementia Research and Care
- Dementia 2018

Welcome message

The Dementia Organizing Committee takes an immense pleasure in inviting you to the eventuality of the 10th World Congress on Dementia and Alzheimers Disease for productive interactions and an opportunity to present their work and develop regional collaborations in the field of Dementia Care.

Dementia 2018 welcomes all the renowned and aspiring researchers, scientists and business delegates, who are significantly putting their effort to improve the life of population with Dementia.

Copenhagen, Denamrk will be the significant venue during August 16 to 18, 2018 with the international speakers from different geographical regions to explore the scientific sessions.

Scientific sessions of Dementia 2018 will be systematized on the theme “Reconnoitering the Challenges in the Era of Dementia Research and Care”

Dementia 2018 anticipates more than 500 participants around the globe with

·         Thought provoking Keynote lectures

·         Interactive Oral and Poster presentations

·         Speculative Workshops

·         Remarkable Exhibitions

·         Extravagant Sponsorship opportunities

·         Media partners and Collaborators

This year conference will offer generous opportunities for all stakeholders in the arena of Neurology, Neuroscience and Dementia to picture their research work worldwide.

The main focus of the Dementia 2018 will be on  Alzheimers diseaseDementia, Imaging Techniques associated with Biomarkers, Various Animal modelsGeriatrics and Cognitive DisorderPathophysiology, Care practice and Awareness, Current Trends and Awareness in Dementia and Alzheimers Disease.

This year’s program, coupled with the Business Opportunity Exchange, is an event you can’t afford to miss!!

Sessions

Dementia-an underlying disease

Dementia | Dementia Congress | Dementia Conferences | Dementia Meetings Alzheimers Conferences | Neurology Conferences | Neuro Disorders Conferences | Neuroscience Conferences

Dementia is a term which generally refers to loss of memory and some other mental abilities which affects the person’s day to day life. Alzheimers disease is the most common type of disease which covers 50-70% cases. The common symptoms of dementia include emotional problems, problem in finding words, lack of motivation etc. The severity of dementia increases with the person’s age. The other common types of diseases which include dementia are vascular dementialewy body dementia, and front temporal dementia.

Related conferences

6th World Congress on Neurology and Neurological disorders, September 28-30, 2018 Toronto, Canada; 2nd International Conference on Sleep Disorders and Medicine, November 28-30, 2018 Atlanta, USA, 2nd International Conference on Central Nervous System Disorders and Therapeutics, December 5-7 2018, Dubai, UAE; 2nd International Conference on Parkinsons Disease and Movement Disorders November 28-30, 2018 Atlanta, USA; International Conference on Neurorehabilitation, July 21-22, 2018 Brisbane, Australia; 7thGlobal Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2018 Vienna, Austria; International Conference on Deep Brain Stimulation (DBS), Germany; 6th Annual Traumatic Brain Injury Conference Washington, United States; 21st International Conference on Brain Tumor Research and Therapy; 17thInternational conference on pediatric neurooncology

Related Societies

Dementia Society of AmericaAlzheimer's Disease International (ADI), Acoustic Neuroma AssociationAicardi Syndrome Foundation and Alliance for Aging ResearchAlzheimers AssociationAlzheimers and Related Disorders Society of IndiaALS Association and ALS Therapy Development InstituteAlternating Hemiplegia of Childhood Foundation and Alzheimer’s Drug Discovery Foundation

 

Alzheimers Disease: Diagnosis and Symptoms

Dementia | Dementia Congress | Dementia Conferences | Dementia Meetings Alzheimers Conferences | Neurology Conferences | Neuro Disorders Conferences | Neuroscience Conferences

Alzheimers is caused by brain cell death. It is a neurological disorder in which the death of brain cells causes memory loss and cognitive decline. The total size of the brain shrinks in Alzheimer's, nerve cells and connections in the tissue progressively reduced, which cannot be seen or tested in the living brain affected by Alzheimer's disease, post-mortem/autopsy will always show tiny inclusions in the nerve tissues, called as plaques and tangles. Plaques are found between the dying cells in the brain - from the build-up of a protein called beta-amyloid (amyloid plaques). The tangles exist in the brain neurons, from a disintegration of second protein, called tau.

Worldwide, with Dementia or Related disorders nearly 44 million people have suffered in 2015,past results shown 35.66 million population  lived with dementia  worldwide in year 2010, with numbers expected to nearly double each twenty years, to 65.7 million in 2030 and 115.4 million in 2050. In 2010, fifty-eight per cent of all population with dementia lived in countries with lower or moderate incomes, with this proportion anticipated to rise to 63% till 2030 and 71% by 2050. This condition is anticipated to double by 2030 and quite triple by 2050 to 115 million.

Related conferences

6th World Congress on Neurology and Neurological disorders, September 28-30, 2018 Toronto, Canada; 2nd International Conference on Sleep Disorders and Medicine, November 28-30, 2018 Atlanta, USA, 2nd International Conference on Central Nervous System Disorders and Therapeutics, December 5-7 2018, Dubai, UAE; 2nd International Conference on Parkinsons Disease and Movement Disorders November 28-30, 2018 Atlanta, USA; International Conference on Neurorehabilitation, July 21-22, 2018 Brisbane, Australia; 7thGlobal Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2018 Vienna, Austria; International Conference on Deep Brain Stimulation (DBS), Germany; 6th Annual Traumatic Brain Injury Conference Washington, United States; 21st International Conference on Brain Tumor Research and Therapy; 17thInternational conference on pediatric neurooncology

Related Societies

Dementia Society of AmericaAlzheimer's Disease International (ADI), Acoustic Neuroma AssociationAicardi Syndrome Foundation and Alliance for Aging ResearchAlzheimers AssociationAlzheimers and Related Disorders Society of IndiaALS Association and ALS Therapy Development InstituteAlternating Hemiplegia of Childhood Foundation and Alzheimer’s Drug Discovery Foundation

 

Vascular Dementia and Stroke

Dementia | Dementia Congress | Dementia Conferences | Dementia Meetings Alzheimers Conferences | Neurology Conferences | Neuro Disorders Conferences | Neuroscience Conferences

Vascular dementia, otherwise called multi-infarct dementia (MID) and vascular intellectual impedance (VCI), is dementia caused by issues in the supply of blood to the mind, normally a progression of minor strokesDementia is a general term describing problems with reasoning, planning, judgment, memory and other thought processes caused by brain damage from impaired blood flow to your brain. People with dementia give dynamic subjective hindrance, intensely or sub acutely as in mellow psychological debilitation, every now and again step-wise, after various cerebrovascular occasions (strokes). According to neurologist , Dementia is the second-most-common form of dementia after Alzheimer's disease (AD).A few people may seem to enhance amongst occasions and decrease after more noiseless strokes. A quickly decaying condition may prompt demise from a stroke, coronary illness, or infectionDementia can be caused by ischemic or hemorrhagic infarcts influencing numerous mind regions, including the foremost cerebral supply route domain, the parietal projections, or the cingulate gurus.

Related conferences

6th World Congress on Neurology and Neurological disorders, September 28-30, 2018 Toronto, Canada; 2nd International Conference on Sleep Disorders and Medicine, November 28-30, 2018 Atlanta, USA, 2nd International Conference on Central Nervous System Disorders and Therapeutics, December 5-7 2018, Dubai, UAE; 2nd International Conference on Parkinsons Disease and Movement Disorders November 28-30, 2018 Atlanta, USA; International Conference on Neurorehabilitation, July 21-22, 2018 Brisbane, Australia; 7thGlobal Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2018 Vienna, Austria; International Conference on Deep Brain Stimulation (DBS), Germany; 6th Annual Traumatic Brain Injury Conference Washington, United States; 21st International Conference on Brain Tumor Research and Therapy; 17thInternational conference on pediatric neurooncology

Related Associations

Alzheimer's Association and Alzheimer's Foundation of America, Lewy Body Dementia Association, Parkinson Society Canada, American Association of Neurological Surgeons, American Academy of Neurology, World Federation of Neurology, Stroke Association, Spanish Society of Neurology, American Academy of Neurology, Alzheimer's Disease International, Association of Parkinsonism and Related Disorders, World Federation of Neurology

 

Dementia with Lewy bodies

Dementia | Dementia Congress | Dementia Conferences | Dementia Meetings Alzheimers Conferences | Neurology Conferences | Neuro Disorders Conferences | Neuroscience Conferences

Around 1.4 million individual is suffering from Lewy body dementia. Because it symptoms resembles to some other diseases such as Alzheimer’s and Parkinson’s so presently it is a widely misdiagnosed dementia. Lewy body is structurally a protein called alpha-synuclein. Lewy bodies dementia is mainly characterized by deposition of lewy body in brain area which regulates behavior, cognition, and movement. This ailment affects the thinking patterns such as ability to understand visual information, memory and executive function. Patients show fluctuation in alertness and attention and various types of problem in movement such as tremors, difficult walking etc.

Related conferences

6th World Congress on Neurology and Neurological disorders, September 28-30, 2018 Toronto, Canada; 2nd International Conference on Sleep Disorders and Medicine, November 28-30, 2018 Atlanta, USA, 2nd International Conference on Central Nervous System Disorders and Therapeutics, December 5-7 2018, Dubai, UAE; 2nd International Conference on Parkinsons Disease and Movement Disorders November 28-30, 2018 Atlanta, USA; International Conference on Neurorehabilitation, July 21-22, 2018 Brisbane, Australia; 7thGlobal Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2018 Vienna, Austria; International Conference on Deep Brain Stimulation (DBS), Germany; 6th Annual Traumatic Brain Injury Conference Washington, United States; 21st International Conference on Brain Tumor Research and Therapy; 17thInternational conference on pediatric neurooncology

Related Associations

Alzheimer's Association and Alzheimer's Foundation of America, Lewy Body Dementia Association, Parkinson Society Canada, American Association of Neurological Surgeons, American Academy of Neurology, World Federation of Neurology, Stroke Association, Spanish Society of Neurology, American Academy of Neurology, Alzheimer's Disease International, Association of Parkinsonism and Related Disorders, World Federation of Neurology

 

Parkinson’s disease

Dementia | Dementia Congress | Dementia Conferences | Dementia Meetings Alzheimers Conferences | Neurology Conferences | Neuro Disorders Conferences | Neuroscience Conferences

Parkinson's disease (PD) is a chronic and progressive movement disorder, meaning that symptoms continue and worsen over time. Nearly one million people in the US are living with Parkinson's disease. The cause is unknown, and although there is presently no cure, there are treatment options such as medication and surgery to manage its symptoms.

Related Conferences

Innovate Dementia 2018, International colloquium on Alzheimer’s and dementia November 29 - 30 Brisbane, Australia, 9th International Conference on Alzheimer’s Disease & Dementia October 16-18, 2018 Rome, Italy, UK Dementia Congress 2018 7 - 9 November 2017, 10th World Congress on Alzheimer’s Disease and Dementia May 30-31, 2018 Osaka, Japan , 9th International Conference on Dementia and Dementia Care 2018, Annual Delaware dementia conference Alzheimer's Association November 15 2018, International Conference on Vascular Dementia February 22-23, 2018 Paris, France

Related Societies & associations

The alzheimer's associationDementia society of AmericaAlzheimer's societylewy body dementia associationDementia UKAlzheimer Scotland, Alzheimer's AustraliaNational council of certified dementia practioners, The Alzheimer’s disease association ,The Malta dementia society

 

Neurodegenerative diseases

Dementia | Dementia Congress | Dementia Conferences | Dementia Meetings Alzheimers Conferences | Neurology Conferences | Neuro Disorders Conferences | Neuroscience Conferences

Neurodegenerative diseases cause your brain and nerves to deteriorate over time. They can change your personality and cause confusion. They can also destroy brain tissue and nerves. Some brain diseases, such as Alzheimer’s disease, may develop as you age. They can slowly impair your memory and thought processes. Other diseases, such as Tay-Sachs disease, are genetic and begin at an early age.

Related conferences

6th World Congress on Neurology and Neurological disorders, September 28-30, 2018 Toronto, Canada; 2nd International Conference on Sleep Disorders and Medicine, November 28-30, 2018 Atlanta, USA, 2nd International Conference on Central Nervous System Disorders and Therapeutics, December 5-7 2018, Dubai, UAE; 2nd International Conference on Parkinsons Disease and Movement Disorders November 28-30, 2018 Atlanta, USA; International Conference on Neurorehabilitation, July 21-22, 2018 Brisbane, Australia; 7thGlobal Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2018 Vienna, Austria; International Conference on Deep Brain Stimulation (DBS), Germany; 6th Annual Traumatic Brain Injury Conference Washington, United States; 21st International Conference on Brain Tumor Research and Therapy; 17thInternational conference on pediatric neurooncology

Related Associations

Alzheimer's Association and Alzheimer's Foundation of America, Lewy Body Dementia Association, Parkinson Society Canada, American Association of Neurological Surgeons, American Academy of Neurology, World Federation of Neurology, Stroke Association, Spanish Society of Neurology, American Academy of Neurology, Alzheimer's Disease International, Association of Parkinsonism and Related Disorders, World Federation of Neurology


Schizophrenia

Dementia | Dementia Congress | Dementia Conferences | Dementia Meetings Alzheimers Conferences | Neurology Conferences | Neuro Disorders Conferences | Neuroscience Conferences

Schizophrenia is a chronic brain disorder that affects about one percent of the population. When schizophrenia is active, symptoms can include delusions, hallucinations, trouble with thinking and concentration, and lack of motivation. However, when these symptoms are treated, most people with schizophrenia will greatly improve over time.

Related conferences

6th World Congress on Neurology and Neurological disorders, September 28-30, 2018 Toronto, Canada; 2nd International Conference on Sleep Disorders and Medicine, November 28-30, 2018 Atlanta, USA, 2nd International Conference on Central Nervous System Disorders and Therapeutics, December 5-7 2018, Dubai, UAE; 2nd International Conference on Parkinsons Disease and Movement Disorders November 28-30, 2018 Atlanta, USA; International Conference on Neurorehabilitation, July 21-22, 2018 Brisbane, Australia; 7thGlobal Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2018 Vienna, Austria; International Conference on Deep Brain Stimulation (DBS), Germany; 6th Annual Traumatic Brain Injury Conference Washington, United States; 21st International Conference on Brain Tumor Research and Therapy; 17thInternational conference on pediatric neurooncology

Related Associations

Alzheimer's Association and Alzheimer's Foundation of America, Lewy Body Dementia Association, Parkinson Society Canada, American Association of Neurological Surgeons, American Academy of Neurology, World Federation of Neurology, Stroke Association, Spanish Society of Neurology, American Academy of Neurology, Alzheimer's Disease International, Association of Parkinsonism and Related Disorders, World Federation of Neurology

 

Geriatrics Dementia and Cognitive Disorder

Dementia | Dementia Congress | Dementia Conferences | Dementia Meetings Alzheimers Conferences | Neurology Conferences | Neuro Disorders Conferences | Neuroscience Conferences

Geriatrics or geriatric medication may be a specialty that focuses on health care of older people. It aims to push health by preventing and treating diseases and disabilities in older adults. there's no set age at that patients are also underneath the care of a specialist or geriatric MD; a MD United Nations agency makes a specialty of the care of older people. Rather, this call is set by the individual patient’s needs, and therefore the availableness of a specialist. It’s vital to notice the distinction between gerontology, the care of aged people, and geriatrics, that is that the study of the aging method itself.

Cognitive disorders square measure a class of mental state disorders that primarily influence learning, memory, perception, and drawback determination, and embody blackout, dementia, and delirium. Whereas anxiety disordersmood disorders, and psychotic disorders can even have an effect on psychological feature and memory functions, the DSM-IV-TR doesn't contemplate these psychological feature disorders, because loss of cognitive function is not the primary (causal) symptom. Causes vary between the various sorts of disorders however most include damage to the memory parts of the brain. Treatments rely on however the disorder is caused. Medication and therapies square measure the foremost common treatments but, for a few sorts of disorders like amnesia, treatments will suppress the symptoms however there is presently no cure.

Related conferences

6th World Congress on Neurology and Neurological disorders, September 28-30, 2018 Toronto, Canada; 2nd International Conference on Sleep Disorders and Medicine, November 28-30, 2018 Atlanta, USA, 2nd International Conference on Central Nervous System Disorders and Therapeutics, December 5-7 2018, Dubai, UAE; 2nd International Conference on Parkinsons Disease and Movement Disorders November 28-30, 2018 Atlanta, USA; International Conference on Neurorehabilitation, July 21-22, 2018 Brisbane, Australia; 7thGlobal Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2018 Vienna, Austria; International Conference on Deep Brain Stimulation (DBS), Germany; 6th Annual Traumatic Brain Injury Conference Washington, United States; 21st International Conference on Brain Tumor Research and Therapy; 17thInternational conference on pediatric neurooncology

Related Associations

Alzheimer's Association and Alzheimer's Foundation of America, Lewy Body Dementia Association, Parkinson Society Canada, American Association of Neurological Surgeons, American Academy of Neurology, World Federation of Neurology, Stroke Association, Spanish Society of Neurology, American Academy of Neurology, Alzheimer's Disease International, Association of Parkinsonism and Related Disorders, World Federation of Neurology

 

Wernicke-Korsakoff Syndrome

Dementia | Dementia Congress | Dementia Conferences | Dementia Meetings Alzheimers Conferences | Neurology Conferences | Neuro Disorders Conferences | Neuroscience Conferences

Wernicke– Korsakoff disorder (WKS) is the consolidated nearness of Wernicke's encephalopathy (WE) and Korsakoff's disorder. Because of the cozy connection between these two issue, individuals with either are normally determined to have WKS, as a solitary disorder.

The reason for the turmoil is thiamine (vitamin B1) lack, which can cause a scope of scatters including beriberi, Wernicke's encephalopathy, and Korsakoff's psychosis. These disarranges may show together or independently. WKS is generally auxiliary to liquor mishandle. It basically causes vision changes, ataxia and hindered memory.

Wernicke's encephalopathy and WKS are most usually found in individuals who are alcoholic, and just 20% of cases are distinguished before death. This disappointment in conclusion of WE and along these lines treatment of the infection prompts passing in around 20% of cases, while 75% are left with lasting cerebrum harm related with WKS. Of those influenced, 25% require long haul regulation keeping in mind the end goal to get successful care.

Related conferences

6th World Congress on Neurology and Neurological disorders, September 28-30, 2018 Toronto, Canada; 2nd International Conference on Sleep Disorders and Medicine, November 28-30, 2018 Atlanta, USA, 2nd International Conference on Central Nervous System Disorders and Therapeutics, December 5-7 2018, Dubai, UAE; 2nd International Conference on Parkinsons Disease and Movement Disorders November 28-30, 2018 Atlanta, USA; International Conference on Neurorehabilitation, July 21-22, 2018 Brisbane, Australia; 7thGlobal Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2018 Vienna, Austria; International Conference on Deep Brain Stimulation (DBS), Germany; 6th Annual Traumatic Brain Injury Conference Washington, United States; 21st International Conference on Brain Tumor Research and Therapy; 17thInternational conference on pediatric neurooncology

Related Associations

Alzheimer's Association and Alzheimer's Foundation of America, Lewy Body Dementia Association, Parkinson Society Canada, American Association of Neurological Surgeons, American Academy of Neurology, World Federation of Neurology, Stroke Association, Spanish Society of Neurology, American Academy of Neurology, Alzheimer's Disease International, Association of Parkinsonism and Related Disorders, World Federation of Neurology

 

Traumatic brain injury

Dementia | Dementia Congress | Dementia Conferences | Dementia Meetings Alzheimers Conferences | Neurology Conferences | Neuro Disorders Conferences | Neuroscience Conferences

Traumatic brain injury (TBI) is unpredictable damage with a wide range of side effects and incapacities. The effect on a man and his or her family can demolish. The reason for this site is to teach and enable guardians and survivors of awful mind wounds. This site expects to facilitate the progress from stun and lose hope at the season of cerebrum damage to adapting and critical thinking.

The side effects of mind wounds and the country's best awful cerebrum damage recovery focuses and asset data.

Related conferences

6th World Congress on Neurology and Neurological disorders, September 28-30, 2018 Toronto, Canada; 2nd International Conference on Sleep Disorders and Medicine, November 28-30, 2018 Atlanta, USA, 2nd International Conference on Central Nervous System Disorders and Therapeutics, December 5-7 2018, Dubai, UAE; 2nd International Conference on Parkinsons Disease and Movement Disorders November 28-30, 2018 Atlanta, USA; International Conference on Neurorehabilitation, July 21-22, 2018 Brisbane, Australia; 7thGlobal Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2018 Vienna, Austria; International Conference on Deep Brain Stimulation (DBS), Germany; 6th Annual Traumatic Brain Injury Conference Washington, United States; 21st International Conference on Brain Tumor Research and Therapy; 17thInternational conference on pediatric neurooncology

Related Associations

Alzheimer's Association and Alzheimer's Foundation of America, Lewy Body Dementia Association, Parkinson Society Canada, American Association of Neurological Surgeons, American Academy of Neurology, World Federation of Neurology, Stroke Association, Spanish Society of Neurology, American Academy of Neurology, Alzheimer's Disease International, Association of Parkinsonism and Related Disorders, World Federation of Neurology

 

Neuropharmacology

Dementia | Dementia Congress | Dementia Conferences | Dementia Meetings Alzheimers Conferences | Neurology Conferences | Neuro Disorders Conferences | Neuroscience Conferences

The action of drug on the nervous system and the neural mechanisms through which they influence behavior is studied in neuropharmacology. Studying these interactions will help the researchers in developing drugs to treat neurological disorderspsychological disorders, pain, addiction and other diseases.

Related conferences

6th World Congress on Neurology and Neurological disorders, September 28-30, 2018 Toronto, Canada; 2nd International Conference on Sleep Disorders and Medicine, November 28-30, 2018 Atlanta, USA, 2nd International Conference on Central Nervous System Disorders and Therapeutics, December 5-7 2018, Dubai, UAE; 2nd International Conference on Parkinsons Disease and Movement Disorders November 28-30, 2018 Atlanta, USA; International Conference on Neurorehabilitation, July 21-22, 2018 Brisbane, Australia; 7thGlobal Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2018 Vienna, Austria; International Conference on Deep Brain Stimulation (DBS), Germany; 6th Annual Traumatic Brain Injury Conference Washington, United States; 21st International Conference on Brain Tumor Research and Therapy; 17thInternational conference on pediatric neurooncology

Related Associations

Alzheimer's Association and Alzheimer's Foundation of America, Lewy Body Dementia Association, Parkinson Society Canada, American Association of Neurological Surgeons, American Academy of Neurology, World Federation of Neurology, Stroke Association, Spanish Society of Neurology, American Academy of Neurology, Alzheimer's Disease International, Association of Parkinsonism and Related Disorders, World Federation of Neurology

 

Amyloid Protein in Alzheimer’s and Dementia

Dementia | Dementia Congress | Dementia Conferences | Dementia Meetings Alzheimers Conferences | Neurology Conferences | Neuro Disorders Conferences | Neuroscience Conferences

The amyloid plaques?and neurofibrillary tangles formation are thought to contribute to the degradation of the neurons (nerve cells) in the brain and the subsequent symptoms of Alzheimer's disease.

Amyloid Plaques: One of the hallmarks of Alzheimer's disease?is the accumulation of amyloid plaques between nerve cells (neurons) in brain. Amyloid generally indicates protein fragments that the body produces normally. Beta amyloid is a protein fragment from an amyloid precursor protein?(APP). In a healthy brain, these protein fragments are broken down and get eliminated. In Alzheimers, the fragments get accumulated to form hard &insoluble plaques.

Neurofibrillary Tangles: Neurofibrillary tangles are insoluble twisted fibers found inside the brain's cells, consisting primarily of a protein called tau, which forms structure called a microtubule. Transport of nutrients and other important substances from one part of the nerve cell to another done by help of microtubule. In Alzheimer's disease, the tau protein is abnormal and results in collapse of the microtubule structures.

This session includes Amyloid Protein and Alzheimer’s Disease, Amyloid beta metabolism in Alzheimer’s, Brain accumulation of toxic amyloid beta, Amyloid Plaques and Neurofibrillary Tangles, Amyloid Neuroimaging and biomarkers, Amyloidosis and Neurodegeneration, The amyloid hypothesis and potential treatmentsAmyloid beta deposition, cognition and brain volume.

Related conferences

6th World Congress on Neurology and Neurological disorders, September 28-30, 2018 Toronto, Canada; 2nd International Conference on Sleep Disorders and Medicine, November 28-30, 2018 Atlanta, USA, 2nd International Conference on Central Nervous System Disorders and Therapeutics, December 5-7 2018, Dubai, UAE; 2nd International Conference on Parkinsons Disease and Movement Disorders November 28-30, 2018 Atlanta, USA; International Conference on Neurorehabilitation, July 21-22, 2018 Brisbane, Australia; 7thGlobal Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2018 Vienna, Austria; International Conference on Deep Brain Stimulation (DBS), Germany; 6th Annual Traumatic Brain Injury Conference Washington, United States; 21st International Conference on Brain Tumor Research and Therapy; 17thInternational conference on pediatric neurooncology

Related Associations

Alzheimer's Association and Alzheimer's Foundation of America, Lewy Body Dementia Association, Parkinson Society Canada, American Association of Neurological Surgeons, American Academy of Neurology, World Federation of Neurology, Stroke Association, Spanish Society of Neurology, American Academy of Neurology, Alzheimer's Disease International, Association of Parkinsonism and Related Disorders, World Federation of Neurology

 

Animal Models and Translational Medicine

Dementia | Dementia Congress | Dementia Conferences | Dementia Meetings Alzheimers Conferences | Neurology Conferences | Neuro Disorders Conferences | Neuroscience Conferences

Animal models for Alzheimer’s disease?it is important to think about the human phenotype and what is being modeled in terms of the animal phenotype. The moderator, Bradley Hyman, professor of neurology at Harvard Medical School, said that animal models of Alzheimer’s disease, based on the genetics of the disease and the closely related frontotemporal dementia, replicate at least some of the pathology. Researchers have been successful at modeling very specific aspects of Alzheimer’s disease in the mouse (e.g., plaques, tangles). Although these are incomplete models of the human disease, they have been well received in the field as potentially relevant models for use in drug discovery.

Patients with Alzheimer’s disease will display both amyloidopathy and tauopathy; however, scientists often focus, in a reductionist way, on one or the other in an animal model. A participant added that even though the anatomy in the mouse is different than the human, mutant tau mice are relatively good models in that they recapitulate tau-dependent neurodegeneration. This has led many companies to focus on antibodies that block tau-dependent neurodegeneration in these mouse models.

This session includes Transgenic models, Pharmacological and lesion models, Natural and semi natural models, Primate models, Zebra fish models, Animal models of human cognitive aging, Development of new animal models, Genetics of translational models, Protein-protein interactions, Ethical issues with animal models.

Related conferences

6th World Congress on Neurology and Neurological disorders, September 28-30, 2018 Toronto, Canada; 2nd International Conference on Sleep Disorders and Medicine, November 28-30, 2018 Atlanta, USA, 2nd International Conference on Central Nervous System Disorders and Therapeutics, December 5-7 2018, Dubai, UAE; 2nd International Conference on Parkinsons Disease and Movement Disorders November 28-30, 2018 Atlanta, USA; International Conference on Neurorehabilitation, July 21-22, 2018 Brisbane, Australia; 7thGlobal Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2018 Vienna, Austria; International Conference on Deep Brain Stimulation (DBS), Germany; 6th Annual Traumatic Brain Injury Conference Washington, United States; 21st International Conference on Brain Tumor Research and Therapy; 17thInternational conference on pediatric neurooncology

Related Associations

Alzheimer's Association and Alzheimer's Foundation of America, Lewy Body Dementia Association, Parkinson Society Canada, American Association of Neurological Surgeons, American Academy of Neurology, World Federation of Neurology, Stroke Association, Spanish Society of Neurology, American Academy of Neurology, Alzheimer's Disease International, Association of Parkinsonism and Related Disorders, World Federation of Neurology

 

Dementia Care Practice & Awareness

Dementia | Dementia Congress | Dementia Conferences | Dementia Meetings Alzheimers Conferences | Neurology Conferences | Neuro Disorders Conferences | Neuroscience Conferences

Related conferences

6th World Congress on Neurology and Neurological disorders, September 28-30, 2018 Toronto, Canada; 2nd International Conference on Sleep Disorders and Medicine, November 28-30, 2018 Atlanta, USA, 2nd International Conference on Central Nervous System Disorders and Therapeutics, December 5-7 2018, Dubai, UAE; 2nd International Conference on Parkinsons Disease and Movement Disorders November 28-30, 2018 Atlanta, USA; International Conference on Neurorehabilitation, July 21-22, 2018 Brisbane, Australia; 7thGlobal Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2018 Vienna, Austria; International Conference on Deep Brain Stimulation (DBS), Germany; 6th Annual Traumatic Brain Injury Conference Washington, United States; 21st International Conference on Brain Tumor Research and Therapy; 17thInternational conference on pediatric neurooncology

Related Associations

Alzheimer's Association and Alzheimer's Foundation of America, Lewy Body Dementia Association, Parkinson Society Canada, American Association of Neurological Surgeons, American Academy of Neurology, World Federation of Neurology, Stroke Association, Spanish Society of Neurology, American Academy of Neurology, Alzheimer's Disease International, Association of Parkinsonism and Related Disorders, World Federation of Neurology

 

Clinical Trials & Case Reports in Dementia

Dementia | Dementia Congress | Dementia Conferences | Dementia Meetings Alzheimers Conferences | Neurology Conferences | Neuro Disorders Conferences | Neuroscience Conferences

The goal of much of the research activity in dementia is to develop interventions for 'treatment' or even 'cure'. The classical bench to bedside paradigm has been disappointing in dementia. There is a long list of putative dementia treatment compounds with favorable pre-clinical and early phase trial data that have been neutral or even potentially harmful when assessed in phase III studies. Lewy body dementia is a common but frequently under diagnosed cause of dementia often mistaken for the more familiar entity of Alzheimer disease. Clinically the distinction is important, because it can have profound implications for management. The diagnosis of Lewy body dementia has important implications. It is associated with a high incidence of neuroleptic sensitivity, necessitating great caution in the use of these common antipsychotic agents. Early studies indicate cholinesterase inhibitors can be beneficial for treating the hallucinations and behavior disturbances that afflict these patients and might also improve cognition.

Related conferences

6th World Congress on Neurology and Neurological disorders, September 28-30, 2018 Toronto, Canada; 2nd International Conference on Sleep Disorders and Medicine, November 28-30, 2018 Atlanta, USA, 2nd International Conference on Central Nervous System Disorders and Therapeutics, December 5-7 2018, Dubai, UAE; 2nd International Conference on Parkinsons Disease and Movement Disorders November 28-30, 2018 Atlanta, USA; International Conference on Neurorehabilitation, July 21-22, 2018 Brisbane, Australia; 7thGlobal Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2018 Vienna, Austria; International Conference on Deep Brain Stimulation (DBS), Germany; 6th Annual Traumatic Brain Injury Conference Washington, United States; 21st International Conference on Brain Tumor Research and Therapy; 17thInternational conference on pediatric neurooncology

Related Associations

Alzheimer's Association and Alzheimer's Foundation of America, Lewy Body Dementia Association, Parkinson Society Canada, American Association of Neurological Surgeons, American Academy of Neurology, World Federation of Neurology, Stroke Association, Spanish Society of Neurology, American Academy of Neurology, Alzheimer's Disease International, Association of Parkinsonism and Related Disorders, World Federation of Neurology

 

Recent Advancement in Treatments of Dementia

Dementia | Dementia Congress | Dementia Conferences | Dementia Meetings Alzheimers Conferences | Neurology Conferences | Neuro Disorders Conferences | Neuroscience Conferences

Epidemiological studies show that, worldwide, the number of people aged over 65 will increase substantially in the next decades and that a considerable proportion of this population will develop dementia. Ample evidence shows that ageing is associated with a high rate of painful conditions, irrespective of cognitive status. The number of patients with dementia who will experience painful conditions is therefore

likely to increase.

Related conferences

6th World Congress on Neurology and Neurological disorders, September 28-30, 2018 Toronto, Canada; 2nd International Conference on Sleep Disorders and Medicine, November 28-30, 2018 Atlanta, USA, 2nd International Conference on Central Nervous System Disorders and Therapeutics, December 5-7 2018, Dubai, UAE; 2nd International Conference on Parkinsons Disease and Movement Disorders November 28-30, 2018 Atlanta, USA; International Conference on Neurorehabilitation, July 21-22, 2018 Brisbane, Australia; 7thGlobal Neurologists Annual Meeting on Neurology and Neuro Surgery, August 22-24, 2018 Vienna, Austria; International Conference on Deep Brain Stimulation (DBS), Germany; 6th Annual Traumatic Brain Injury Conference Washington, United States; 21st International Conference on Brain Tumor Research and Therapy; 17thInternational conference on pediatric neurooncology

Related Associations

Alzheimer's Association and Alzheimer's Foundation of America, Lewy Body Dementia Association, Parkinson Society Canada, American Association of Neurological Surgeons, American Academy of Neurology, World Federation of Neurology, Stroke Association, Spanish Society of Neurology, American Academy of Neurology, Alzheimer's Disease International, Association of Parkinsonism and Related Disorders, World Federation of Neurology

 

 

Market Analysis

About 46 million people in the world has been estimated to be suffering with dementia by 2015 and it may be increased to 50 million (approx. data) by 2017.whereas in America, about 5.5 million people of all ages are estimated to be suffering with dementia. Among 5.5 millions, It’s been calculated that the people under 65 are about 2, 00,000 suffering with dementia which is referred by the term “younger onset dementia”. By 2020, the people above 65 with dementia are estimated around 5.8 million. In America, Alzheimers is accounted as the 6th leading cause of death. The cost of cumulative care for Alzheimers patients is estimated to be $236 billion in 2016 and the global cost is estimated to be $605 billion which is equal to the 1% of the world gross product. US Scientists have found that at the age of 65, 1/6th of women have more tendencies to develop Alzheimers disease compared to the man with chance of 1 in 11. Dementia rates were high among the African-American women compared to that of the Asia-American women and same way is calculated in the case of men in USA. However based on the environmental risk factors, one can develop the symptoms regardless gender.

 Goal of world congress on Dementia 2018 is to furnish an outstanding program for exchange of ideas and interventions by the researchers and scientists who have been inventing the new pathways and novel inter cultural methods for various treatments associated with dementia. We strive to make Dementia 2018 a success with your support and eminent talks about the dementia and perspective care and research works on dementia. We assure you the world class facilities and hospitality entirely during the conference.

 The 35.6 million people with dementia across world in 2010 are expected to be double by 2030 to about 65.7 million, and nearly double by 2050 to 115.4 million. It is estimated that as many as 5.1 million people of US are thriving with Alzheimers disease and it can be increased with the raising ages. There are currently 390,000 New York population with Alzheimers disease or related dementia and it is approximated to be doubled by 2025 nearly an increase of 18% especially to the people aged 65 and above. In New York alone, Medicaid for Alzheimers costs around $4.5 billion each year which is the highest cost recorded compared with other cities in USA. It is estimated that nearly 1/3 of seniors who die each year have Alzheimers or a related Dementia and it is also estimated that there are about 1 million Alzheimers and dementia unpaid caregivers.

 The risk of dementia increases with the age and causes mainly due to the brain cell degeneration. Due to the dysfunction of blood vessels after degeneration, blood vessels are unable to receive the oxygen levels properly and hence due to the lack in the supply of oxygen, the brain cells are not able to work properly and thus the risk of memory occurs. Based on the physiological factors and genetic relocation the type of dementia varies from individual to individual but the most common disease is Alzheimers which attacks 3/4th of dementia population. The risk of dementia is reaching heights in the developing countries and USA stands in the one of the top 5 countries in developing dementia and related diseases.

Denmark Market report

It is predicted that the global dementia and movement disorder treatment market will grow more than 4% by 2021 compared with the present CAGR .In addition to that the research analysts identifies the need for disease modifying drugs(DMDS) as one of the primary growth factors for this market. The treatment for dementia is conducted through therapeutic approaches that provide symptomatic relief as the drugs intended for the treatment only treat the symptoms. The existing drugs in the market are unable to attack the underlying cause of the disease and prolong the treatment cost and time duration. This will in turn increase the demand for DMD since it will safely modify the progression of a disease.

About Conference

Dementia 2018 welcomes all the renowned and aspiring researchers, scientists and business delegates, who are significantly putting their effort to improve the life of population with Dementia.

Dementia 2018 is an international congress which expects more than 50 speakers and more than 100 participants from all across the world. Dementia 2018 will provide you chance to get expose with the latest research and technology developing in the field of Dementia and Alzheimers disease. This is perfect stage to grow you research incite and participate in the scientific discussion. Along with this Dementia 2018 will help the participant to develop international academic and business network.

The main focus of the Dementia 2018 will be on  Alzheimers diseaseDementia, Imaging Techniques associated with Biomarkers, Various Animal models, Geriatrics and Cognitive Disorder, Pathophysiology, Care practice and Awareness, Current Trends and Awareness in Dementia and Alzheimers Disease.

Why to Attend?

This platform will give you an international stage to conduct demonstrations, workshops, and symposiums to showcase your services and product. Dementia 2018 will avail you chance to distribute information and to meet potential national and international delegates. Participant can approach the invited scientist to explore the new product line possibility and exchange the idea of developing the novel therapeutics or products. World-renowned speakers, the most recent researches, innovations, and the Novel updates in Dementia field are hallmarks of this congress.

Why Denmark

In Denmark 390,000 population are suffering with Alzheimers disease or related dementia. Many statics shows that in 2025, the number of population of aged 65 and older will increase by 18% or approximately 460,000. Denmark also has very well renowned research institute which are doing the excellent work in the field of Dementia and Dementia Care. Denmark is also a populous city and fast growing pharmaceutical industry.

In Denmark many institutes and associations are working in the field of DementiaAlzheimers and other related neurological disorders. Moreover, the government organize many public awareness and patient care giving programs in association with various Alzheimers or Dementia organizations. Denmark spends $5779 per month on only memory care. A major public health burden  facing Denmark State, Alzheimers is projected to impact 700,000 individuals by 2025. In addition, the disease plays a major economic role by increasing medical costs and affecting employers of caregivers. In New York only Alzheimers disease costs  more than $20 billion per year.

Through Dementia 2018 we are trying to provide an interactive platform for the participants joining us all across the world so that they can take advantage of the event to progress in the research field of Dementia and Alzheimers Diseases.

 

Target Audience

    ·         Presidents

    ·         Directors

    ·         Neurologist

    ·         Neuroscientist

    ·         Neurosurgeon

    ·         Neurology Professor

    ·         Neurology Assistant and Associate Professor

    ·         Post doctorate and Doctorate

    ·         Dementia Researchers

    ·         Medical College and Hospitals

    ·         Business Entrepreneurs

    ·         Training Institutes

    ·         Software developing companies

    ·         Medical Devices Manufacturing Companies

    ·         Data Management Companies

    ·         Pharmaceutical industries and Biotech Company

    ·         Dementia community, society and associations

    ·         Other experts in Dementia and dementia care

    Organizing Committee
    OCM Member
    Abdulkader Al-Daif
    Professor and Consultant Neurologist, Neurology
    King Saud University
    Riyadh, Saudi Arabia
    OCM Member
    Alberto Musto
    Eastern Virginia Medical School
    Virginia, USA
    OCM Member
    Dr. Lin Zhang
    Medical Director
    Deep Brain Stimulation Program UC Davis Health System
    Davis, USA
    OCM Member
    Marina Zueva
    Professor, Neurology
    Moscow Helmholtz Research Institute of Eye Diseases
    Moscow, Russia
    OCM Member
    Francisco Javier Aparicio Rebollo
    Spanish National Research Council-University of Seville
    Barcelona, Spain
    OCM Member
    Hannes Richter
    Fraunhofer Institute for Ceramic Technologies and Systems
    Dresden, Germany
    OCM Member
    Stephen Skaper
    University of Padua
    Rome, Italy
    OCM Member
    Alain Fymat
    President/CEO
    International Institute of Medicine and Science
    California, USA
    OCM Member
    Hans von Holst
    Chairman, Neurosurgery and Neuroengineering
    Karolinska Institutet
    Linkoping, Sweden
    Renowned Speakers

    To Collaborate Scientific Professionals around the World

    Conference Date August 16-18, 2018
    Speaker Oppurtunity
    Poster Oppurtunity Available
    e-Poster Oppurtunity Available
    Join The Discussion

    Allied Academies Global Conference Directory

    Mail us at

    Drop us a mail for program enquiry
    dementia@alliedconference.com
    Sponser/Exhibiting/advertising
    dementia@alliedconference.com
    General queries
    dementia@alliedconference.com
    More details about sponsorship:sponsors@alliedacademies.com

    Terms and Conditions


    Responsibility

    Delegates are personally responsible for their belongings at the venue. The Organizers will not be held responsible for any stolen or missing items belonging to Delegates, Speakers or Attendees; due to any reason whatsoever.

    Insurance

    Registration fees do not include insurance of any kind.

    Transportation

    Please note that any (or) all transportation and parking is the responsibility of the registrant.

    Press/Media

    Press permission must be obtained from allied academies Conferences Organizing Committee prior to the event. The press will not quote speakers or delegates unless they have obtained their approval in writing. The allied academies is an objective third-party nonprofit organization. This conference is not associated with any commercial meeting company.

    Requesting an Invitation Letter

    For security purposes, letter of invitation will be sent only to those individuals who had registered for the conference. Once your registration is complete, please contact to request a personalized letter of invitation.
    Regarding refunds, all bank charges will be for the registrants account.

    Cancellation, Postponement and Transfer of Registration

    Cancellation Policy

    If an allied academy cancels this event for any reason, you will receive a credit for 100% of the registration fee paid. You may use this credit for another allied academies event which must occur within one year from the date of cancellation.

    Postponement

    If allied academies   postpones an event for any reason and you are unable or unwilling to attend on rescheduled dates, you will receive a credit for 100% of the registration fee paid. You may use this credit for another e allied academies event which must occur within one year from the date of postponement.

    Transfer of registration

    All fully paid registrations are transferable to other persons from the same organization, if registered person is unable to attend the event. Transfers must be made by the registered person in writing to dementia@alliedmeetings.com . Details must be included the full name of replacement person, their title, contact phone number and email address. All other registration details will be assigned to the new person unless otherwise specified.

    Registration can be transferred to one conference to another conference of Allied academies. if the person is unable to attend one of conferences.

    However, Registration cannot be transferred if it is intimated within 14 days of respective conference.

    The transferred registrations will not be eligible for Refund.


    Visa Information

    Keeping in view of increased security measures, we would like to request all the participants to apply for Visa as soon as possible.
    Allied academies will not directly contact embassies and consulates on behalf of visa applicants. All delegates or invitees should apply for Business Visa only.
    Important note for failed visa applications: Visa issues cannot come under the consideration of cancellation policy of Allied academies, including the inability to obtain a visa.

    Refund Policy

    If the registrant is unable to attend, and is not in a position to transfer his/her participation to another person or event, then the following refund arrangements apply:
    Keeping in view of advance payments towards Venue, Printing, Shipping, Hotels and other overheads, we had to keep Refund Policy is as following slabs-

    Before 60 days of the conference: Eligible for Full Refund less $100 service Fee
    Within 60-30 days of Conference: Eligible for 50% of payment Refund
    Within 30 days of Conference: Not eligible for Refund
    E-Poster Payments will not be refunded.

    Accommodation Cancellation Policy

    Accommodation Providers (Hotels) have their own cancellation policies, and they generally apply when cancellations are made less than 30 days prior to arrival. Please contact us as soon as possible, if you wish to cancel or amend your accommodation. Allied academies will advise the cancellation policy of your accommodation provider, prior to cancelling or amending your booking, to ensure you are fully aware of any non-refundable deposits.
     



    Authorization Policy


    Copyright © 2018-2019 Allied Academies, All Rights Reserved.